VACCINATION AGAINST HPV-ASSOCIATED DISEASES AND CERVICAL CANCER: THEORETICAL AND PRACTICAL ASPECTS

Abstract

The article presents data about the frequency of the human papilloma virus associated pathology in the world, Europe and the RF increasing each year. The most frequently occurring pathologic states caused by human papilloma virus are provided. It was stated that the problem of HPV-associated diseases concerns not only women but men. The most frequent types of oncogenic viruses causing the malignant pathology of the reproductive system are Type 16 and 18 viruses. Vaccines providing prevention of the cervical cancer are developed for these two types of viruses. The quadrilent vaccine is effective with respect to lesions of the female genital organs and of the vagina in the form of condylomas. The article demonstrates the first results of HPVvaccines in various countries of the world that testify about its high effectiveness for anogenital condylomas and precancer cervical changes, that considerably reduced in populations of such countries as Australia, Germany, Sweden etc. Issues on side effects related to application of both vaccines are discussed. Currently according to the conducted survey studies no safety problems were established for women and men when using quardilent as well as bivalent vaccines.Currently vaccination against HPV is included in national immunization programs in 60 countries of the world, including 6 countries where vaccination of boys is implemented.In December 2014, FDA approved the new vaccine Gardasil-9 for girls and women as well as for boys for prevention of precancer lesions of reproductive organs the effectiveness of which is confirmed by results of international multi-center studies.

Keywords

• hpv-infection
• cervical
• vaginal and vulvar precancer and cancer
• anal cancer in women
• in men
• vaccines against hpv and cervical
• vaginal
• vulvar and anal cancer
• vaccine effectiveness
• vaccine gardasil-9